HIV 1 News and Research

RSS

Trial of early antiviral therapy for COVID-19 shows no significant benefit

A new preprint research paper examines the efficacy of using three antivirals in various combinations in early infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

African children and adolescents hospitalized with COVID-19 experience much higher mortality rates than Europeans or North Americans of the same age, according to a recently published study conducted by researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology Nigeria (IHVN).

16 Feb 2022

The emergence of infectious diseases from the "germ’s eye view”

The study highlighted that the disruption caused by the COVID-19 pandemic has shown that human societies remain ill-prepared and susceptible to novel infectious diseases.

16 Feb 2022

The long-term consequences of SARS-CoV-2 infection in people with HIV

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from the United States (US) analyzed a cohort of patients with human immunodeficiency virus (HIV) (PWH) recovering from coronavirus disease 2019 (COVID-19) and characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in these patients.

15 Feb 2022

A third known case of HIV remission involving stem cell transplant documented

A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at today's Conference on Retroviruses and Opportunistic Infections (CROI).

15 Feb 2022

SARS-CoV-2 ORF6 inhibits mRNA export to favour viral translation and suppress innate signalling

A recent study posted to the bioRxiv* pre-print server investigated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inhibit the human immune response against viral infection.

15 Feb 2022

Study shows expression of viral proteases may be used to quantitate SARS-CoV-2 infected cells

A new study describes a new method to quantify SARS-CoV-2 infection, which is much simpler and faster compared to existing methods.

14 Feb 2022

Nitazoxanide shows promise for COVID-19 treatment in animal model

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that Nitazoxanide (NTZ), an oral drug, broadly inhibits replication of several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in preclinical models of infection.

13 Feb 2022

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by "drug tourism" unabated by the closure of the international border due to the COVID-19 pandemic.

12 Feb 2022

Sexual health programs adopting a pleasure-inclusive approach can improve safe sex behaviors

Sexual health programs that include sexual desire and sexual pleasure can improve knowledge and attitudes around sex, as well as condom use compared to those that do not, according to research published in the open access journal PLOS ONE.

12 Feb 2022

Machine learning highly effective at identifying SARS-CoV-2 variants

...

9 Feb 2022

Implications of the SARS-CoV-2 pandemic on influenza epidemics

A new study investigated the effect of low circulating seasonal influenza virus during the SARS-CoV-2 pandemic on the antibody titers against influenza during the same period.

9 Feb 2022

Novel fast-spreading HIV-1 variant found circulating in the Netherlands

Researchers identify 17 individuals who were infected with a highly virulent variant of HIV-1.

7 Feb 2022

Discovery shows promise for development of a new non-hormonal contraceptive

A discovery that blocks the normal transition of semen from a thick gel to a liquid shows promise for development of a new form of non-hormonal, over-the-counter contraception.

7 Feb 2022

"Drug checking" programs have unexpected benefits, study finds

A recent study has found that so-called "drug checking" programs have unexpected benefits, allowing public health programs to reach and work with people who use drugs who would otherwise not access services such as HIV testing.

7 Feb 2022

UiA collaborates with The Hospital of Southern Norway to develop a digital treatment for HIV patients

The HIV medicines in use today are very effective, and face-to-face follow-up consultations in hospitals are unnecessary for a large part of the patient group.

7 Feb 2022

Researchers discover a new function of anti-HIV-1 antibodies

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures.

6 Feb 2022

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

4 Feb 2022

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers.

3 Feb 2022

Exploring human milk oligosaccharides as a method of COVID-19 prevention

New research was conducted to ascertain whether antiviral and immunomodulatory activities of human milk oligosaccharides can be efficacious in the prevention and treatment against COVID-19.

3 Feb 2022

HIV 1 News and Research

Trial of early antiviral therapy for COVID-19 shows no significant benefit

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

The emergence of infectious diseases from the "germ’s eye view”

The long-term consequences of SARS-CoV-2 infection in people with HIV

A third known case of HIV remission involving stem cell transplant documented

SARS-CoV-2 ORF6 inhibits mRNA export to favour viral translation and suppress innate signalling

Study shows expression of viral proteases may be used to quantitate SARS-CoV-2 infected cells

Nitazoxanide shows promise for COVID-19 treatment in animal model

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

Sexual health programs adopting a pleasure-inclusive approach can improve safe sex behaviors

Machine learning highly effective at identifying SARS-CoV-2 variants

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Novel fast-spreading HIV-1 variant found circulating in the Netherlands

Discovery shows promise for development of a new non-hormonal contraceptive

"Drug checking" programs have unexpected benefits, study finds

UiA collaborates with The Hospital of Southern Norway to develop a digital treatment for HIV patients

Researchers discover a new function of anti-HIV-1 antibodies

Wistar researchers takes a promising step in the direction of developing HIV vaccine

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Exploring human milk oligosaccharides as a method of COVID-19 prevention

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News